Delcath Systems (DCTH) Competitors

Delcath Systems (NASDAQ:DCTH) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

Which has more risk & volatility, DCTH or LMAT?

Delcath Systems has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500.

Do analysts recommend DCTH or LMAT?

Delcath Systems currently has a consensus target price of $24.00, suggesting a potential upside of 111.64%. LeMaitre Vascular has a consensus target price of $97.83, suggesting a potential upside of 16.91%. Given Delcath Systems' stronger consensus rating and higher probable upside, equities analysts plainly believe Delcath Systems is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Which has preferable valuation & earnings, DCTH or LMAT?

LeMaitre Vascular has higher revenue and earnings than Delcath Systems. Delcath Systems is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$37.21M	10.61	-$26.39M	-$0.50	-22.68
LeMaitre Vascular	$219.86M	8.60	$44.04M	$1.98	42.26

Is DCTH or LMAT more profitable?

LeMaitre Vascular has a net margin of 19.96% compared to Delcath Systems' net margin of -26.38%. LeMaitre Vascular's return on equity of 13.53% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	-26.38%	-29.44%	-20.75%
LeMaitre Vascular	19.96%	13.53%	9.78%

Do insiders and institutionals believe in DCTH or LMAT?

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are held by institutional investors. 17.4% of Delcath Systems shares are held by company insiders. Comparatively, 9.5% of LeMaitre Vascular shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Does the media prefer DCTH or LMAT?

In the previous week, LeMaitre Vascular had 3 more articles in the media than Delcath Systems. MarketBeat recorded 4 mentions for LeMaitre Vascular and 1 mentions for Delcath Systems. LeMaitre Vascular's average media sentiment score of 0.87 beat Delcath Systems' score of 0.65 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company	Overall Sentiment
Delcath Systems	Positive
LeMaitre Vascular	Positive

Summary

LeMaitre Vascular beats Delcath Systems on 10 of the 16 factors compared between the two stocks.